Neurology Today in 5

In this week's podcast, Neurology Today 's editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology. 

In this week's podcast, Neurology Today 's editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.

In this week's podcast, Neurology Today 's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  

In this week's podcast, Neurology Today 's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  

In this week's podcast, Neurology Today 's editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.  

In this week's podcast, Neurology Today 's editor-in-chief discusses what's known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.  

In this week's podcast, Neurology Today 's editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year's residency match.